Luyan Pharma Co.,Ltd.

Shenzhen Stock Exchange 002788.SZ

Luyan Pharma Co.,Ltd. Price to Book Ratio (P/B) on January 14, 2025: 1.03

Luyan Pharma Co.,Ltd. Price to Book Ratio (P/B) is 1.03 on January 14, 2025, a -8.50% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Luyan Pharma Co.,Ltd. 52-week high Price to Book Ratio (P/B) is 1.24 on October 08, 2024, which is 20.36% above the current Price to Book Ratio (P/B).
Luyan Pharma Co.,Ltd. 52-week low Price to Book Ratio (P/B) is 0.82 on February 05, 2024, which is -20.02% below the current Price to Book Ratio (P/B).
Luyan Pharma Co.,Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 1.04.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 002788.SZ

Luyan Pharma Co.,Ltd.

CEO	Mr. Jinxiang Wu
IPO Date	Feb. 18, 2016
Location	China
Headquarters	No. 1004, Anling Road
Employees	5,475
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen, China.

Key trends

Past 5 years